Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | KIF11 | P52732 | 2/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | KCNN4 | O15554 | 3/20 | 0.39 |
| ▸ | ESR1 | P03372 | 2/20 | 0.39 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | SHBG | P04278 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28873040 | 0.83 | KIF11 (0.50) | TAAR1MAPK1KIF11CYP2C19ALDH1A1 | |
| SCHEMBL7812087 | 0.80 | TAAR1 (0.48) | TAAR1MAPK1KIF11CYP2C19HIF1A | |
| SCHEMBL23511279 | 0.80 | ALDH1A1 (0.46) | TAAR1MAPK1KIF11CYP2C19HIF1A | |
| SCHEMBL31590503 | 0.80 | SMN1; SMN2 (0.48) | TAAR1MAPK1CYP2C19HIF1AALDH1A1 | |
| SCHEMBL42933 | 0.79 | SHBG (0.60) | TAAR1MAPK1CYP2C19HIF1AALDH1A1 | |
| SCHEMBL17711602 | 0.77 | TAAR1 (0.40) | TAAR1MAPK1KIF11CYP2C19HIF1A | |
| SCHEMBL9013022 | 0.75 | TAAR1 (0.43) | TAAR1MAPK1CYP2C19HIF1AALDH1A1 | |
| SCHEMBL4667150 | 0.75 | ALDH1A1 (0.43) | TAAR1MAPK1CYP2C19HIF1AALDH1A1 | |
| SCHEMBL8407090 | 0.75 | TAAR1 (0.43) | TAAR1MAPK1CYP2C19HIF1AALDH1A1 | |
| SCHEMBL17885867 | 0.75 | ALDH1A1 (0.46) | TAAR1MAPK1CYP2C19HIF1AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240066132-A1 | NOVEL FATTY ACIDS AND THEIR USE IN CONJUGATION TO BIOMOLECULES | NOVARTIS AG (CH) | 2024-02-29 | — | — | US | disclosed |
| US-11752211-B2 | Fatty acids and their use in conjugation to biomolecules | NOVARTIS AG (CH) | 2023-09-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240066132-A1 | NOVEL FATTY ACIDS AND THEIR USE IN CONJUGATION TO BIOMOLECULES | FABP1, FABP2, FABP3 | TAAR1 2214/4885MAPK1 2103/4885KIF11 1551/4885 |
| US-11752211-B2 | Fatty acids and their use in conjugation to biomolecules | FABP1, FABP2, FABP3 | TAAR1 2094/4885MAPK1 1908/4885KIF11 1799/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.